rxstat › Shortages › Digoxin Immune Fab

Digoxin Immune Fab (Digifab) shortage status

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Digoxin Immune Fab has no current shortage reported in Canada. It has been in shortage before; the history is below.

An antidote used to treat dangerous digoxin overdose or toxicity.

Products affected

0 / 1

Reports on file

Shortage history

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Resolved

DIGIFAB

40MG · POWDER FOR SOLUTION · BTG INTERNATIONAL INC

DIN 02361043 · ended Jul 25, 2025 · Demand increase for the drug.

Resolved

DIGIFAB

40MG · POWDER FOR SOLUTION · BTG INTERNATIONAL INC

DIN 02361043 · ended Jan 12, 2024 · Demand increase for the drug.

Resolved

DIGIFAB

40MG · POWDER FOR SOLUTION · BTG INTERNATIONAL INC

DIN 02361043 · ended May 4, 2018 · Demand increase for the drug.

What's happening

There are no active shortage reports for Digoxin Immune Fab. Health Canada has 3 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Digoxin Immune Fab is classified under “ALL OTHER THERAPEUTIC PRODUCTS” (ATC V03AB).

Recent changes

No changes recorded yet.

Common questions

What is Digoxin Immune Fab used for?

An antidote used to treat dangerous digoxin overdose or toxicity.

When will Digoxin Immune Fab be back in stock in Canada?

Digoxin Immune Fab has no active shortage; supply is normal per Health Canada reports.

Why is Digoxin Immune Fab in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs (all other therapeutic products)

Mesna (Uromitexan) Widespread shortage 3 of 3 reported products affected · est. return Aug 31, 2026 Polystyrene Sulfonate (Solystat) Widespread shortage 3 of 6 reported products affected · est. return Oct 9, 2026 Deferasirox Partial shortage 1 of 21 reported products affected Dexrazoxane (Zinecard) Partial shortage 1 of 3 reported products affected Hydroxocobalamin (Cyanokit) Partial shortage 1 of 1 reported products affected Leucovorin Partial shortage 1 of 6 reported products affected · est. return Aug 28, 2026

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.